DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast" report to their offering.
Osteoporosis Companies Drugs (Merck, Sanofi, Novartis, Eli Lilly and Amgen) Sales & Forecast provides a comprehensive analysis of the current state of the market and likely future evolution over the next 5 years. This 21 page report with 12 Figures provides a sales analysis of covered companies.
Worldwide Osteoporosis - Company Wise Drugs Sales Analysis (2010 - 2019)
1) Merck
2) Sanofi
3) Novartis
4) Eli Lilly
5) Amgen
Key Topics Covered:
1. Worldwide Osteoporosis Drugs Company Market Share (2010 - 2019)
2. Key Players Osteoporosis Drugs Sales & Forecast
2.1 Merck Osteoporosis Drugs Sales (2010 - 2019)
2.2 Sanofi Osteoporosis Drugs Sales (2010 - 2019)
2.3 Novartis Osteoporosis Drugs Sales (2010 - 2019)
2.4 Eli Lilly Osteoporosis Drugs Sales (2010 - 2019)
2.5 Amgen Osteoporosis Drugs Sales (2010 - 2019)
For more information about this report visit http://www.researchandmarkets.com/research/z6ph62/osteoporosis
Related Topics: Endocrine and Metabolic Disorder Drugs
Also Available
Osteoporosis Global Clinical Trials Review, H1, 2016
Global Osteoporosis Partnering Deals and Agreements 2010 to 2016
